[1]
“Evaluating Loco-Regional Hypofractionated versus Conventional Radiotherapy in Post-Mastectomy Breast Cancer”, JOC, vol. 24, no. 8s, pp. 131–140, Oct. 2025, doi: 10.64149/J.Carcinog.24.8s.131-140.